New BIOVEGEN partner: MACAMI BIOTECH S.L.

A new entity has joined BIOVEGEN as a partner. MACAMI BIOTECH S.L. is the first company in the world created to enhance the biotechnology of microalgae in the nutraceutical sector, developing innovative solutions to prevent chronic diseases typical of modern society. In a supplement market that is opaque and saturated with mere ingredients, Macami stands out for its quality and transparency, showing the origin and cultivation method of the microalgae, and offering complete nutraceutical formulas for specific objectives, whose ingredients are scientifically validated. Additionally, it collaborates with CSIC and CIAL on projects aimed at generating knowledge and turning it into accessible products for society as a whole. With a focus on research, efficacy, safety, and sustainability, Macami aims to integrate its nutraceuticals into the daily routine of any individual to enhance the overall well-being of society.